First biosimilar monoclonal antibody distribution licence secured

Mundipharma International Corporation Limited has announced that it has secured a distribution licence from Celltrion Healthcare Hungary Kft for Remsima (infliximab).
Source: Pharmacy Europe - Category: Drugs & Pharmacology Authors: Tags: *** Editor's Pick Biosimilars mAbs Drug development Dermatology Gastroenterology Rheumatology biosimilar monoclonal antibody infliximab Latest News Mundipharma Remsima Source Type: news